Home
News
In Focus
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
It’s not sports! Overzealous fans should respect their idols
Experts in China studies impressed by city’s transformation during site visits
Sunday
- Subscribe
Related News
Bawang's IPO draws almost US$9b
Source: Agencies |
00:00 UTC+8 June 27, 2009
|
Print Edition
Print Edition
CHINESE herbal shampoo maker Bawang International Group drew nearly US$9 billion in retail orders for its initial public offering in Hong Kong, reports said yesterday, amid signs of renewed investor confidence.
The strong response was likely to lead Bawang, which is based in the southern city of Guangzhou in Guangdong Province, to price its shares at or close to the maximum price of HK$2.38 (12 US cents), the South China Morning Post and other reports said, citing unnamed sources.
Bawang is the latest among several China-based companies whose shares have been avidly sought by investors seeking fresh opportunities for gains.
Mainland share markets are resuming initial public offerings after a nine-month moratorium, with a small drug maker -- Guilin Sanjin Pharmaceutical Co --- due to debut on Monday in Shenzhen, the smaller of China's two stock exchanges.
The offering by Bawang, which has hired film celebrity Jackie Chan to promote its products, was 420 times oversubscribed, triggering a clawback mechanism that increased the retail section to half of its HK$1.67 billion IPO from the original 10 percent, the reports said.
Other firms are also faring well.
China Qinfa, a coal trading and transport company, raised HK$630 million in its recent Hong Kong IPO. Its shares begin trading on Friday.
Share prices in Hong Kong and Chinese mainland have been rising, with the Hang Seng Index up about 28 percent since the beginning of the year, and the Shanghai Composite Index up 60 percent.
Investors have been encouraged by strong initial gains made by several other newcomers.
The strong response was likely to lead Bawang, which is based in the southern city of Guangzhou in Guangdong Province, to price its shares at or close to the maximum price of HK$2.38 (12 US cents), the South China Morning Post and other reports said, citing unnamed sources.
Bawang is the latest among several China-based companies whose shares have been avidly sought by investors seeking fresh opportunities for gains.
Mainland share markets are resuming initial public offerings after a nine-month moratorium, with a small drug maker -- Guilin Sanjin Pharmaceutical Co --- due to debut on Monday in Shenzhen, the smaller of China's two stock exchanges.
The offering by Bawang, which has hired film celebrity Jackie Chan to promote its products, was 420 times oversubscribed, triggering a clawback mechanism that increased the retail section to half of its HK$1.67 billion IPO from the original 10 percent, the reports said.
Other firms are also faring well.
China Qinfa, a coal trading and transport company, raised HK$630 million in its recent Hong Kong IPO. Its shares begin trading on Friday.
Share prices in Hong Kong and Chinese mainland have been rising, with the Hang Seng Index up about 28 percent since the beginning of the year, and the Shanghai Composite Index up 60 percent.
Investors have been encouraged by strong initial gains made by several other newcomers.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
